GENE ONLINE|News &
Opinion
Blog

Innovation
M&A
Targeted cancer radiopharma specialist – ENDOCYTE INC.’s acquisition
2018-10-23
Roche’s breast cancer drug, Kadcyla succeeds phase III trial
2018-10-22
Finding new pharmacological approach for neuroblastoma treatment
2018-10-16
Tracking “OFF THE SHELF” CAR-T Cell therapy & an IPO worth $100M
2018-10-15
R&D
A new player emerges in the non-small cell lung cancer (NSCLC) therapy scene
2018-10-11
Cambridge startup, GO Therapeutics make $195 million deal with Roche
2018-10-05
Cancer immunotherapy researchers earn prestigious Nobel for 2018
2018-10-02
Long term HIV suppression by new combination therapy
2018-10-01
Clash of three migraines medications & cost benefit for patients
2018-10-01
Watching Biosimilar Entrants Alongside Blockbuster Patent Expiry Countdown
2018-09-25
CRISPR mediated overexpression of cocaine hydrolyzing enzyme in mouse skin patch protects against lethal overdose
2018-09-20
Latest Developments in Precision Medicine and Molecular Detection
2018-09-19
Ceasefire update on CRISPR’s USA patent battle
2018-09-17
Targeting tumor heterogeneity with salvo of sequencing
2018-09-06
Transposon sheds light on genes associated with developmental brain diseases
2018-08-15
1 51 52 53 54
LATEST
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
Singapore’s NUS Medicine Launches Centre for Sustainable Medicine
2023-11-20
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
Scroll to Top